David Mosedale, CTO at Methuselah Health
RxCelerate Acquires Methuselah Health and Launches ProQuant™ World-Beating Proteomics Service
November 22, 2022 08:00 ET | RxCelerate
CAMBRIDGE, England, Nov. 22, 2022 (GLOBE NEWSWIRE) -- RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery...
In silica modeling
RxCelerate Launch RxNfinity™: A Next-Generation Machine Learning-Enabled Small Molecule Discovery Platform
July 19, 2022 08:00 ET | RxCelerate
CAMBRIDGE, England, July 19, 2022 (GLOBE NEWSWIRE) -- RxCelerate, a leading international outsourced drug discovery and development platform, today revealed details of a new small molecule discovery...